High throughput P450 inhibition screens in early drug discovery

This publication has 57 references indexed in Scilit:

• Highly Miniaturized Formats for In Vitro Drug Metabolism Assays Using Vivid® Fluorescent Substrates and Recombinant Human Cytochrome P450 Enzymes
  SLAS Discovery, 2005
• Prediction of binding modes for ligands in the cytochromes P450 and other heme‐containing proteins
  Proteins-Structure Function and Bioinformatics, 2005
• KOHONEN MAPS FOR PREDICTION OF BINDING TO HUMAN CYTOCHROME P450 3A4
  Drug Metabolism and Disposition, 2004
• GENERATION AND VALIDATION OF RAPID COMPUTATIONAL FILTERS FOR CYP2D6 AND CYP3A4
  Drug Metabolism and Disposition, 2003
• Challenges and solutions to ultra-high-throughput screening assay miniaturization: submicroliter fluid handling
  Drug Discovery Today, 2000
• Mechanism-Based Inactivation of Human Cytochrome P450 1A2 by Furafylline: Detection of a 1:1 Adduct to Protein and Evidence for the Formation of a Novel Imidazomethide Intermediate
  Biochemistry, 1998
• In vitro assessment of human cytochrome P450
  Xenobiotica, 1998
• Clinical Pharmacokinetics of Mibefradil
  Clinical Pharmacokinetics, 1998
• Inhibition and Induction of Cytochrome P450 and the Clinical Implications
  Clinical Pharmacokinetics, 1998
• Clinically Significant Drug Interactions with Cyclosporin
  Clinical Pharmacokinetics, 1996